Cargando…

IFN-β is a macrophage-derived effector cytokine facilitating the resolution of bacterial inflammation

The uptake of apoptotic polymorphonuclear cells (PMN) by macrophages is critical for timely resolution of inflammation. High-burden uptake of apoptotic cells is associated with loss of phagocytosis in resolution phase macrophages. Here, using a transcriptomic analysis of macrophage subsets, we show...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumaran Satyanarayanan, Senthil, El Kebir, Driss, Soboh, Soaad, Butenko, Sergei, Sekheri, Meriem, Saadi, Janan, Peled, Neta, Assi, Simaan, Othman, Amira, Schif-Zuck, Sagie, Feuermann, Yonatan, Barkan, Dalit, Sher, Noa, Filep, János G., Ariel, Amiram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677895/
https://www.ncbi.nlm.nih.gov/pubmed/31375662
http://dx.doi.org/10.1038/s41467-019-10903-9
Descripción
Sumario:The uptake of apoptotic polymorphonuclear cells (PMN) by macrophages is critical for timely resolution of inflammation. High-burden uptake of apoptotic cells is associated with loss of phagocytosis in resolution phase macrophages. Here, using a transcriptomic analysis of macrophage subsets, we show that non-phagocytic resolution phase macrophages express a distinct IFN-β-related gene signature in mice. We also report elevated levels of IFN-β in peritoneal and broncho-alveolar exudates in mice during the resolution of peritonitis and pneumonia, respectively. Elimination of endogenous IFN-β impairs, whereas treatment with exogenous IFN-β enhances, bacterial clearance, PMN apoptosis, efferocytosis and macrophage reprogramming. STAT3 signalling in response to IFN-β promotes apoptosis of human PMNs. Finally, uptake of apoptotic cells promotes loss of phagocytic capacity in macrophages alongside decreased surface expression of efferocytic receptors in vivo. Collectively, these results identify IFN-β produced by resolution phase macrophages as an effector cytokine in resolving bacterial inflammation.